Cancer Care Ontario | Cancer Care Ontario

241 Results

Guidelines and Advice

Minimal Residual Disease Testing in Acute Leukemia

Status: Current
ID: MOTAC-6
Version: 2

Sep 2020

Guidelines and Advice

Pandemic Planning Clinical Guideline for Patients with Cancer

Status: Current
Version: 2

Dec 2021

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2019

Status: Current
ID: PET 2019-2
Version: N/A

Jun 2020

Guidelines and Advice

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Status: Current
ID: ES 23-2
Version: N/A

Jun 2020

Statistical Reports

Indice de qualité du système de prévention 2020

Oct 2020

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Guidelines and Advice

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Status: Current

Apr 2021

Guidelines and Advice

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Status: Current

Apr 2020

Guidelines and Advice

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Status: Current

Oct 2019

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2020

Status: Current
ID: PET 2020-1
Version: N/A

Nov 2020

Guidelines and Advice

Enhancing Clinical Cancer Genetic Service Delivery in Ontario - Recommendations for a New Model of Care

Status: Current
Version: 1.0

Dec 2020

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Status: Current
ID: 7-A-2018-3

Feb 2021

Minimal Residual Disease Testing in Acute Leukemia

Pandemic Planning Clinical Guideline for Patients with Cancer

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2019

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Indice de qualité du système de prévention 2020

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2020

Enhancing Clinical Cancer Genetic Service Delivery in Ontario - Recommendations for a New Model of Care

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Pages